Black Diamond Therapeutics, Inc.
BDTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001701541
No open-market purchases or sales by Black Diamond Therapeutics, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $64.9M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Black Diamond Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 59
- −10 vs. Q3 2022
- Shares held
- 21.1M
- −441.1K (−2.1%) vs. Q3 2022
- Total value
- $37.9M
- +$1.54M (+4.2%) vs. Q3 2022
- New holders
- 9
- 8 more added
- Sold out
- 19
- 26 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 96 | $64.9M |
| Q1 2026 | 104 | $82.0M |
| Q4 2025 | 104 | $92.0M |
| Q3 2025 | 91 | $147.0M |
| Q2 2025 | 94 | $95.8M |
| Q1 2025 | 85 | $63.0M |
| Q4 2024 | 88 | $102.5M |
| Q3 2024 | 96 | $211.9M |
| Q2 2024 | 90 | $217.9M |
| Q1 2024 | 88 | $199.9M |
| Q4 2023 | 76 | $107.1M |
| Q3 2023 | 73 | $106.8M |
| Q2 2023 | 74 | $209.2M |
| Q1 2023 | 50 | $40.6M |
| Q4 2022 | 59 | $37.9M |
| Q3 2022 | 69 | $36.3M |
| Q2 2022 | 74 | $52.9M |
| Q1 2022 | 87 | $63.5M |
| Q4 2021 | 95 | $123.7M |
| Q3 2021 | 101 | $206.3M |
| Q2 2021 | 102 | $309.6M |
| Q1 2021 | 113 | $705.5M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Black Diamond Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 195 | $0 | 0.00% | −176−47.4% | Reduced |
| CWM, LLC | 9 | $0 | 0.00% | 00.0% | Unchanged |
| TSFG, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 9 | $16 | 0.00% | −281−96.9% | Reduced |
| Investors Research Corp | 30 | $54 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $63 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 36 | $65 | 0.00% | 00.0% | Unchanged |
| New England Capital Financial Advisors LLC | 24 | $72 | 0.00% | +24 | New |
| GWM Advisors LLC | 113 | $173 | 0.00% | +113 | New |
| CoreCap Advisors, LLC | 120 | $216 | 0.00% | +120 | New |
| Citigroup Inc | 135 | $243 | 0.00% | −438−76.4% | Reduced |
| Wells Fargo & Company | 239 | $430 | 0.00% | −496−67.5% | Reduced |
| Federation des caisses Desjardins du Quebec | 280 | $504 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 552 | $1.00K | 0.00% | −1,474−72.8% | Reduced |
| US Bancorp | 700 | $1.26K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 1,201 | $2.16K | 0.00% | +1,201 | New |
| Advisor Group Holdings, Inc. | 2,782 | $5.00K | 0.00% | +522+23.1% | Added |
| Tower Research Capital LLC (TRC) | 3,465 | $6.00K | 0.00% | −810−18.9% | Reduced |
| UBS Group AG | 3,433 | $6.18K | 0.00% | −1,942−36.1% | Reduced |
| Cambridge Investment Research Advisors, Inc. | 11,231 | $20.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 12,814 | $23.1K | 0.00% | −2,272−15.1% | Reduced |
| Jane Street Group, LLC | 12,914 | $23.2K | 0.00% | +12,914 | New |
| Belvedere Trading LLC | 17,295 | $31.1K | 0.02% | +17,295 | New |
| Bank of New York Mellon Corp | 18,191 | $32.7K | 0.00% | −74−0.4% | Reduced |
| Barclays PLC | 19,351 | $34.8K | 0.00% | −1,584−7.6% | Reduced |
| Ergoteles LLC | 20,212 | $36.4K | 0.00% | −30,135−59.9% | Reduced |
| HSBC Holdings PLC | 24,156 | $43.2K | 0.00% | +110.0% | Added |
| Morgan Stanley | 31,202 | $56.2K | 0.00% | −197,987−86.4% | Reduced |
| Marquette Asset Management, LLC | 34,400 | $61.9K | 0.02% | +34,400 | New |
| Beacon Capital Management, LLC | 35,615 | $64.1K | 0.02% | 00.0% | Unchanged |
| AE Wealth Management LLC | 35,947 | $64.7K | 0.00% | −100.0% | Reduced |
| Goldman Sachs Group Inc | 37,006 | $66.6K | 0.00% | −17,972−32.7% | Reduced |
| Northern Trust Corp | 37,983 | $68.4K | 0.00% | 00.0% | Unchanged |
| State of Wisconsin Investment Board | 41,200 | $74.2K | 0.00% | −23,300−36.1% | Reduced |
| Dimensional Fund Advisors LP | 52,522 | $95.0K | 0.00% | −7,524−12.5% | Reduced |
| Acadian Asset Management LLC | 53,365 | $95.0K | 0.00% | +53,365 | New |
| Susquehanna International Group, LLP | 65,814 | $118.5K | 0.00% | −23,782−26.5% | Reduced |
| State Street Corp | 76,384 | $137.5K | 0.00% | 00.0% | Unchanged |
| DAFNA Capital Management LLC | 97,500 | $175.5K | 0.05% | −216,100−68.9% | Reduced |
| Bridgeway Capital Management, LLC | 125,000 | $225.0K | 0.01% | 00.0% | Unchanged |
| Tekla Capital Management LLC | 131,990 | $237.6K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 143,664 | $258.6K | 0.00% | −64,229−30.9% | Reduced |
| MPM Oncology Impact Management LP | 144,888 | $260.8K | 0.07% | −95,000−39.6% | Reduced |
| Federated Hermes, Inc. | 155,219 | $279.4K | 0.00% | −4,329−2.7% | Reduced |
| K2 Principal Fund, L.P. | 158,192 | $284.7K | 0.08% | −873,319−84.7% | Reduced |
| Two Sigma Advisers, LP | 212,500 | $382.5K | 0.00% | −2,100−1.0% | Reduced |
| Renaissance Technologies LLC | 220,613 | $397.0K | 0.00% | +2,913+1.3% | Added |
| Geode Capital Management, LLC | 265,290 | $477.0K | 0.00% | +743+0.3% | Added |
| EcoR1 Capital, LLC | 282,131 | $507.8K | 0.02% | +282,131 | New |
| Newtyn Management, LLC | 315,000 | $567.0K | 0.12% | −35,000−10.0% | Reduced |
| Millennium Management LLC | 524,557 | $944.0K | 0.00% | +177,577+51.2% | Added |
| Vanguard Group Inc | 757,585 | $1.36M | 0.00% | +487+0.1% | Added |
| Citadel Advisors LLC | 773,798 | $1.39M | 0.00% | +733,149+1,803.6% | Added |
| BlackRock Inc. | 993,769 | $1.79M | 0.00% | −269,748−21.3% | Reduced |
| Artal Group S.A. | 1,646,517 | $2.96M | 0.17% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,014,858 | $3.63M | 0.20% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,589,904 | $4.66M | 0.09% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,448,757 | $6.21M | 0.35% | −1,0880.0% | Reduced |
| Bellevue Group AG | 5,400,839 | $9.72M | 0.13% | +683,726+14.5% | Added |
| Deutsche Bank AG | 0 | $0 | 0.00% | −321,602−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −82,881−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −22,486−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −21,281−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,813−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,764−100.0% | Sold out |
| Redmond Asset Management, LLC | 0 | $0 | 0.00% | −15,978−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,973−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,734−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,541−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,703−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −476−100.0% | Sold out |
| Global Trust Asset Management, LLC | 0 | $0 | 0.00% | −634−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −341−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −106−100.0% | Sold out |